Moreover, CCL19 is upregulated in carotid atherosclerosis, and it enables the enhancement of proliferative capacity and MMP-1 expression in vascular smooth muscle cells, thereby contributing to the pro-atherogenic potential (Halvorsen et al., 2014). This evidence concerns the gene CCL19 and carotid atherosclerosis.